CRISPRi-Mediated Epigenetic Suppression of TERT Reduces Cell Growth in Non-Small-Cell Lung Cancer Cells
Cells · 24.06.2026 · 15 (13) · 1150
DOI: 10.3390/cells15131150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 24.06.2026. Verfasst von Seong-Ho Park und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, College of Natural Sciences, Hanyang University, Seongdong-gu, Seoul 04763, Republic of Korea. Hauptthemen laut MEDLINE: Telomerase, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Epigenesis, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, the Korea US Collaborative Research Fund, the Ministry of Education.
Abstract (Originalsprache)
TERT, the catalytic subunit of telomerase, is aberrantly activated in most cancers and represents an attractive therapeutic target. However, conventional TERT-targeting strategies, including chemical inhibitors and siRNA, are limited by several issues, such as insufficient efficacy and off-target effects. In this study, we investigated whether dCas9-KRAB-mediated CRISPR interference (CRISPRi) could overcome the limitations by transcriptional repression of TERT without DNA cleavage. We first assessed the efficacy of the dCas9-KRAB system by applying it to H1299 non-small-cell lung cancer cells and observed reduction in TERT expression up to approximately 80% and significant decreases in cell viability and growth. Transcriptome-wide analysis showed limited detectable changes in non-target-gene expression under the conditions tested. Together, the results suggest that dCas9-KRAB-mediated CRISPRi could serve as a proof-of-principle approach for targeted repression of TERT in cancer cells with limited detectable effects on non-target-gene expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Science, College of Natural Sciences, Hanyang University, Seongdong-gu, Seoul 04763, Republic of Korea.
- Department of Biomedical Science, Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul 04763, Republic of Korea.
- Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul 04763, Republic of Korea.
- Department of Pre-Medicine, College of Medicine, Hanyang University, Seoul 04763, Republic of Korea.
- Department of Medicine (AgeTech-Service Convergence Major), College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
- Department of Neurosurgery, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.
ORCID-Profile: Seong-Ho Park, Juyoung Hong, Minjeong Kim
Förderung
- Ministry of Science and ICT
- the Korea US Collaborative Research Fund
- the Ministry of Education
- National Research Foundation of Korea
Zitieren
APA
Park, S. H., Hong, J., Hwang, W., Kim, M., Yu, H. J., Bae, T., Lee, H. K., Lee, J. Y., Lee, Y. C., Park, C. K., & Hur, J. K. (2026). CRISPRi-Mediated Epigenetic Suppression of TERT Reduces Cell Growth in Non-Small-Cell Lung Cancer Cells. Cells, 15(13), 1150. https://doi.org/10.3390/cells15131150
Vancouver
Park SH, Hong J, Hwang W, Kim M, Yu HJ, Bae T, et al. CRISPRi-Mediated Epigenetic Suppression of TERT Reduces Cell Growth in Non-Small-Cell Lung Cancer Cells. Cells. 2026;15(13):1150. doi:10.3390/cells15131150
BibTeX
@article{Park2026,
author = {Park, Seong-Ho and Hong, Juyoung and Hwang, Woochang and Kim, Minjeong and Yu, Hyeon Jong and Bae, Taegeun and Lee, Hyomin K and Lee, Ji Yeoun and Lee, Young Chan and Park, Chul-Kee and Hur, Junho K},
title = {CRISPRi-Mediated Epigenetic Suppression of TERT Reduces Cell Growth in Non-Small-Cell Lung Cancer Cells},
journal = {Cells},
year = {2026},
volume = {15},
number = {13},
pages = {1150},
doi = {10.3390/cells15131150}
}
EUVIMED